Stock listing
CLDI Stock Price, News, Filings & Events — Calidi Biotherapeutics, Inc.
Selected listing: CLDI · AMEX · USD · US
This page tracks Calidi Biotherapeutics, Inc.'s CLDI:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CLDI:AMEX. CLDI:AMEX is the stock-level entry point for investors researching Calidi Biotherapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Calidi Biotherapeutics, Inc. (ticker: CLDI) is a public company operating in the American market, focusing on innovative biotherapeutic solutions. With a market capitalization of approximately $1.93 million, Calidi is dedicated to advancing its research and development efforts in the biotechnology sector. The company aims to address significant medical needs through its unique therapeutic approaches.

- Ticker
- CLDI:AMEX
- Asset type
- Stock
- Market cap
- $3.2M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- AMEX
- Currency
- USD
Calidi Biotherapeutics, Inc. CLDI:AMEX stock context
This page tracks Calidi Biotherapeutics, Inc.'s CLDI:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CLDI:AMEX. CLDI:AMEX is the stock-level entry point for investors researching Calidi Biotherapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Calidi Biotherapeutics, Inc. (ticker: CLDI) is a public company operating in the American market, focusing on innovative biotherapeutic solutions. With a market capitalization of approximately $1.93 million, Calidi is dedicated to advancing its research and development efforts in the biotechnology sector. The company aims to address significant medical needs through its unique therapeutic approaches.
Latest news from Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 13, 2026
Calidi Announces Reverse Stock Split, Expected to Begin Trading on a 1-for-16 Split Adjusted Basis on July 31, 2026
July 20, 2026
Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strateg...
June 16, 2026
Calidi Biotherapeutics Announces Investor Webinar on June 9, 2026
June 8, 2026
Calidi Biotherapeutics Announces Online Abstract Acceptances at the 2026 ASCO Annual Meeting
May 26, 2026
Research Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics, Inc. investor report
Review AI stock analysis and investor report context for CLDI:AMEX.
Calidi Biotherapeutics, Inc. company profile
View the public company page for Calidi Biotherapeutics, Inc. on 6ix.
Calidi Biotherapeutics, Inc. news
Read company news and market updates connected to Calidi Biotherapeutics, Inc..
Calidi Biotherapeutics, Inc. investor events
Find investor webinars, events, and replay context for Calidi Biotherapeutics, Inc..